Biosyent Stock Market Value
RX Stock | CAD 11.26 0.08 0.71% |
Symbol | Biosyent |
Biosyent Price To Book Ratio
Biosyent 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Biosyent's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Biosyent.
12/13/2022 |
| 12/02/2024 |
If you would invest 0.00 in Biosyent on December 13, 2022 and sell it all today you would earn a total of 0.00 from holding Biosyent or generate 0.0% return on investment in Biosyent over 720 days. Biosyent is related to or competes with Cipher Pharmaceuticals, Covalon Technologies, and Knight Therapeutics. BioSyent Inc., a specialty pharmaceutical company, sources, acquires or in-licenses, develops, and sells various pharmac... More
Biosyent Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Biosyent's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Biosyent upside and downside potential and time the market with a certain degree of confidence.
Downside Deviation | 1.94 | |||
Information Ratio | (0.03) | |||
Maximum Drawdown | 9.42 | |||
Value At Risk | (3.47) | |||
Potential Upside | 3.93 |
Biosyent Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Biosyent's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Biosyent's standard deviation. In reality, there are many statistical measures that can use Biosyent historical prices to predict the future Biosyent's volatility.Risk Adjusted Performance | 0.0389 | |||
Jensen Alpha | 0.1069 | |||
Total Risk Alpha | (0.25) | |||
Sortino Ratio | (0.03) | |||
Treynor Ratio | (0.27) |
Biosyent Backtested Returns
At this stage we consider Biosyent Stock to be not too volatile. Biosyent secures Sharpe Ratio (or Efficiency) of 0.0423, which signifies that the company had a 0.0423% return per unit of risk over the last 3 months. We have found thirty technical indicators for Biosyent, which you can use to evaluate the volatility of the firm. Please confirm Biosyent's Mean Deviation of 1.28, risk adjusted performance of 0.0389, and Downside Deviation of 1.94 to double-check if the risk estimate we provide is consistent with the expected return of 0.0822%. Biosyent has a performance score of 3 on a scale of 0 to 100. The firm shows a Beta (market volatility) of -0.27, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Biosyent are expected to decrease at a much lower rate. During the bear market, Biosyent is likely to outperform the market. Biosyent right now shows a risk of 1.95%. Please confirm Biosyent skewness, and the relationship between the value at risk and day median price , to decide if Biosyent will be following its price patterns.
Auto-correlation | 0.77 |
Good predictability
Biosyent has good predictability. Overlapping area represents the amount of predictability between Biosyent time series from 13th of December 2022 to 8th of December 2023 and 8th of December 2023 to 2nd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Biosyent price movement. The serial correlation of 0.77 indicates that around 77.0% of current Biosyent price fluctuation can be explain by its past prices.
Correlation Coefficient | 0.77 | |
Spearman Rank Test | 0.75 | |
Residual Average | 0.0 | |
Price Variance | 1.14 |
Biosyent lagged returns against current returns
Autocorrelation, which is Biosyent stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Biosyent's stock expected returns. We can calculate the autocorrelation of Biosyent returns to help us make a trade decision. For example, suppose you find that Biosyent has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
Biosyent regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Biosyent stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Biosyent stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Biosyent stock over time.
Current vs Lagged Prices |
Timeline |
Biosyent Lagged Returns
When evaluating Biosyent's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Biosyent stock have on its future price. Biosyent autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Biosyent autocorrelation shows the relationship between Biosyent stock current value and its past values and can show if there is a momentum factor associated with investing in Biosyent.
Regressed Prices |
Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Biosyent Stock Analysis
When running Biosyent's price analysis, check to measure Biosyent's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biosyent is operating at the current time. Most of Biosyent's value examination focuses on studying past and present price action to predict the probability of Biosyent's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biosyent's price. Additionally, you may evaluate how the addition of Biosyent to your portfolios can decrease your overall portfolio volatility.